A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines

PLoS ONE - United States
doi 10.1371/journal.pone.0009001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

SET-NUP214 Fusion in Acute Myeloid Leukemia- And T-Cell Acute Lymphoblastic Leukemia-Derived Cell Lines

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2009English

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology
Cancer ResearchOncology
2019English

Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative Study

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Semisynthetic Derivatives of Fradcarbazole a and Their Cytotoxicity Against Acute Myeloid Leukemia Cell Lines

English

Azacitidine and Lenalidomide as an Alternative Treatment for Refractory Acute Myeloid Leukemia: A Case Report

Sao Paulo Medical Journal
Medicine
2014English

The Cell of Origin and the Leukemia Stem Cell in Acute Myeloid Leukemia

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2019English

Venetoclax Plus Decitabine Induced Complete Remission With Molecular Response in Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplantation

American Journal of Hematology
Hematology
2018English

Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Azacitidine Causes Prolonged Neutropenia in an Elderly Patient With Primary Myelofibrosis Transformed to Acute Myeloid Leukemia

Journal of Blood & Lymph
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy